Clinical Trial

Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out whether a type of gentle nerve stimulation, called transcutaneous auricular Vagus Nerve Stimulation (taVNS), can help improve how the body regulates heart rate and blood pressure in people with Parkinson's Disease (PD). Problems with heart rate and blood pressure control are common and can make it harder for people to exercise or do daily activities. By using this non-invasive form of nerve stimulation and testing how it affects the body's natural responses, this study hopes to learn if taVNS could be a helpful tool to support physical therapy and improve overall function.
Protocol Amendment History 1 change
critical Phase changed: not applicable -> Phase 1 2026-06-19
Trial Details
NCT Number NCT07557706
Lead Sponsor University of Alabama at Birmingham
Conditions PARKINSON DISEASE (Disorder)
Enrollment 24 participants
Start Date 2025-09-15
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-18